Optometrist · Harlingen, TX
NPI
1902834963
Since 2006
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1205 N ED Carey Dr
Harlingen, TX, 78550
Phone (956) 423-2100
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
683 services
Medicare patients, 2024
354
Average age 74
Drug cost, 2024
$2.4M
3,334 prescriptions
Company payments, 2025
$34K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lauro Guerrero III was code 92012 (ophthalmological e&m), 248 times for 174 patients. In total Lauro Guerrero III billed 683 services in 15 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 248 | 174 | $56.53 | $14K |
| 92014 Ophthalmological E&M | Office | 174 | 164 | $84.17 | $15K |
| 92133 Computerized Ophthalmic Imaging | Office | 70 | 64 | $24.11 | $1,688 |
| 92004 Ophthalmological E&M | Office | 60 | 60 | $76.45 | $4,587 |
| 65778 Eye | Office | 33 | 19 | $827.72 | $27K |
| 92134 Computerized Ophthalmic Imaging | Office | 32 | 32 | $30.05 | $962 |
| 92083 Vision, Hearing, and Speech Services | Office | 30 | 30 | $42.23 | $1,267 |
| 99214 Office E&M - Established | Office | 14 | 14 | $104.60 | $1,464 |
By year: 2022 $284K for 1,419 services; 2023 $161K for 975 services; 2024 $67K for 683 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lauro Guerrero III prescribed most often to Medicare patients was Xiidra (Lifitegrast), with 870 prescriptions and refills. In total Lauro Guerrero III wrote 3,334 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xiidra Lifitegrast | 870 | 1,856 | 450 | $1.2M |
| Latanoprost Generic | 591 | 1,376 | 218 | $7,990 |
| Lumigan Bimatoprost | 329 | 716 | 121 | $204K |
| Restasis Cyclosporine | 255 | 500 | 105 | $303K |
| Miebo Perfluorohexyloctane/Pf | 184 | 217 | 93 | $156K |
| Xdemvy Lotilaner | 149 | 216 | 138 | $290K |
| Timolol Maleate Generic | 132 | 296 | 46 | $1,753 |
| Cyclosporine Generic | 121 | 239 | 59 | $73K |
| Brimonidine Tartrate Generic | 105 | 214 | 43 | $3,050 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 79 | 157 | 27 | $14K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 68 | 136 | 18 | $995 |
| Combigan Brimonidine Tartrate/Timolol | 47 | 86 | 17 | $21K |
| Vyzulta Latanoprostene Bunod | 38 | 54 | 12 | $17K |
| Rhopressa Netarsudil Mesylate | 37 | 57 | 14 | $20K |
| Dorzolamide Hcl Generic | 33 | 68 | 11 | $619 |
Brand drugs: 2,392 claims; generic drugs: 942 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lauro Guerrero III $34K ($34K in general payments such as food, travel and fees) from 13 companies. The largest payer was Bausch & Lomb Americas Inc. with $32K.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 89 | $32K |
| Tarsus Pharmaceuticals, Inc. TARS | 17 | $558 |
| Abbvie Inc. ABBV | 22 | $500 |
| Dompe US, Inc. | 9 | $343 |
| Alcon Vision LLC ALC | 2 | $239 |
| Harrow Eye, LLC | 2 | $186 |
| RxSight Inc RXST | 1 | $145 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $142 |
| Oyster Point Pharma, Inc. | 5 | $138 |
| Glaukos Corporation GKOS | 1 | $121 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.